| Danone SA (FR0000120644) | |||
68,22 EURStand (close): 14.07.25 |
 |
 |
|
Nachrichten |
||
| Datum / Uhrzeit | Titel | Bewertung |
| 07.07.25 13:40:59 | Exclusive-Nestle chair's exit followed rising unease over direction, investors say |  |
| By John Revill, Oliver Hirt and Richa Naidu ZURICH/LONDON (Reuters) -Nestle's recent announcement that Chairman Paul Bulcke will step down followed rising investor unease over the food group's share price, the tenure of previous CEO Mark Schneider and concerns its corporate governance model was out of date, investors told Reuters. Support for Bulcke, 70, was ebbing away due to doubts about Nestle's recovery after the pandemic, when sales volumes flagged in 2023 as the world's largest packaged food maker increased prices to offset rising raw material costs, four Nestle investors said. There was also discontent over Bulcke's loyalty to Schneider during that tough period, as well as Nestle's practice of making former CEOs chairmen, they said. Schneider was eventually ousted last August and replaced by Nestle veteran Laurent Freixe. The maker of Nescafe instant coffee and KitKat chocolate bars said on June 18 that Bulcke, CEO from 2008 to 2016, would step down as chair in April 2026 and be replaced by vice chairman Pablo Isla, a former chairman and CEO of Spanish fashion retailer Inditex. "Nestle is not in crisis mode, but it's the right time for a change," said Ingo Speich, head of sustainability and corporate governance at Deka Investment, a top-30 Nestle investor which voted against Bulcke at this year's AGM on April 16. "We are big supporters of independent chairmen, but after being on the board for more than a decade, Bulcke was no longer independent," added Speich. "Nestle has been too much like a closed shop in the past." Bulcke was not available to comment on this story. His departure will mark the end of a near 50-year career that saw him rise from marketing trainee to the very top. Responding to a Reuters request for comment on this story, Nestle spokesperson Christoph Meier said Bulcke chose not to seek re-election at a time when Freixe was well established, and the company's strategic direction was clear and firm. "This timing ensures a smooth transition, providing ample time and space for the new leadership team to settle in," Meier said, noting the firm had reviewed its succession plans in June. But the timing of Bulcke's exit - announced soon after he was re-elected for another year, and a year before his mandatory retirement age - was unusual, analysts and investors say. Bulcke, chairman since 2017, was due to retire in 2027 under Nestle's rules. Several top-30 investors told Reuters they had been unhappy with Bulcke for years, with some seeking his departure either privately or at shareholder meetings. Story Continues "The time has been right for Mr. Bulcke to step aside for quite some time," said one, who declined to be named. Bulcke's shareholder backing has been declining. In April, he won re-election with 84.8% shareholder support. While apparently substantial, it was well below the level chairs usually get in Switzerland. In 2017, he received almost 96%. "This was a clear sign that many investors did not appreciate him anymore," the investor said. "He shouldn't have been chairman in the first place - we don't like a CEO becoming chairman without cooling off periods." FRESH START Two previous powerful Nestle chairmen, Peter Brabeck and Helmut Maucher, had also been CEO. "Chairmen who are former CEOs can be resistant to change," said Kuno Schedler, a corporate governance expert at the University of St. Gallen, Switzerland. Shareholders also criticised Bulcke's decision to retain Schneider when Nestle's performance struggled after 2022. Adding to the disquiet were scandals such as Nestle's use of banned treatments to purify bottled water in France, and supply chain problems in the United States. Yet when Schneider was finally let go, it came as a shock. "Safe haven companies like Nestle should never surprise the market," one shareholder said. "The former CEO was doing roadshows with investors shortly before he had to go." Shareholders have also been concerned by the performance of the group's share price - which fell 42% between 2022 and 2024 - lagging rivals like Unilever and Danone which gained 15% and 19% respectively. Investors were also worried about high debt which threatened future payouts. Net debt at the end of 2024 was 2.9 times adjusted earnings before interest, taxes, depreciation and Amortization, up from 2.5 times at the end of 2023. "Shareholders only want one thing: returns. And if they're not there, then people are unhappy," said one investor. Investors and analysts said incoming chair Isla showed strong leadership at Zara-owner Inditex, cheering a potentially fresh approach to driving growth at Nestle. One of Isla's first priorities will be to define the profile of the next CEO, said Vontobel analyst Jean-Philippe Bertschy. Freixe is 63, so questions have been raised about how long he will remain in the top job. Other tasks will include deciding what to do with Nestle's roughly 40 billion euro ($47.11 billion) stake in French cosmetics giant L'Oreal, and whether to keep the company's struggling frozen foods business. "We need better execution at Nestle," said Simon Jaeger, a portfolio manager at Nestle investor Flossbach von Storch. "That's why it's good to have a breath of fresh air in the position of chairman. "Inditex is one of the best-managed companies in an ultra-competitive sector. Pablo Isla played a leading role in this. And because he already knows Nestle, he is a good solution." ($1 = 0.8490 euros) (Reporting by John Revill, Oliver Hirt in Zurich and Richa Naidu in LondonEditing by Dave Graham and Susan Fenton) |
||
| 04.07.25 16:00:00 | Danone: Information on the total number of voting rights and shares | |
| DANONE DANONE French Société anonyme with a capital of €170,348,620.75. Registered Office: 17, boulevard Haussmann, 75009 Paris. Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) Date Total number of shares Total number of voting rights 30/06/2025 681,394,483 Total number of theoretical voting rights(1) : 721,120,820 Total number of exercisable voting rights(2) : 683,024,152 (1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. (2) The total number of exercisable voting rights (or ”net” voting rights) is calculated without taking into account the shares with suspended voting rights. It is published to ensure that the public is properly informed in accordance with the recommendation made by the AMF on July 17, 2007. Attachment Voting Rights and Shares 300625 Visualizza commenti |
||
| 01.07.25 17:15:00 | Novo Holdings portfolio company Kate Farms acquired by Danone | |
| Novo Holdings led Kate Farms' Series C financing in 2022 and supported its continued growth as the company's largest institutional investor Transaction highlights the Planetary Health investment team's role in backing scalable science-driven solutions that drive systems-level change in the food and nutrition industries Kate Farms to expand further as it becomes part of Danone's North America Medical Nutrition business SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- Novo Holdings, a leading life science investor, today announced that its portfolio company Kate Farms has been acquired by Danone, a global leader in food and nutrition. The acquisition represents a significant milestone for Kate Farms, a pioneer in plant-based clinical nutrition, and underscores Novo Holdings' commitment to supporting innovative companies that improve health outcomes and quality of life for people with unmet needs. Kate Farms is a US-based provider of plant-based, organic nutrition formulas developed to better meet the needs of patients with medical conditions and individuals seeking daily nutritional support. Founded in 2012, what began as a family's determination to help their daughter thrive has grown into a leading provider of clinically supported, allergen-free products trusted by patients, caregivers, and clinicians nationwide. Its formulas are available in more than 1,400 hospitals across the country, providing a high-quality alternative for families and patients who have previously had limited or ineffective nutrition options. Today, Kate Farms is the #1 Doctor Recommended Plant-Based Brand. Novo Holdings was among the largest institutional investors in Kate Farms, having led the company's $75 million Series C financing in September 2022. Since then, Novo Holdings has supported the company's clinical research, product innovation, and efforts to expand access to medically tailored nutrition. Kartik Dharmadhikari, Partner of Novo Holdings, said: "Kate Farms has emerged as a category leader in specialized medical nutrition by pairing scientific and clinical innovation with a deep understanding of patients' needs — particularly for those who cannot rely on standard diets. Novo Holdings is proud to have supported the company's growth from its early stages to this landmark transaction. This partnership is a powerful example of how our Planetary Health team's investment strategy drives market leadership and enables better health outcomes through scalable, science-driven solutions." Story Continues Brett Matthews, Danone North America Medical Nutrition Chairman and Chief Executive Officer said: "Becoming part of Danone – an organization that shares our mission to improve lives through nutrition – is a really proud moment for Kate Farms and will make a positive difference to the people, families and communities we serve. Together, we are in a better position to provide high-quality nutrition to those with a wide range of health needs. We are deeply appreciative of the support that investors Novo Holdings, Goldman Sachs, Kaiser Ventures, Main Street Advisors, Aliment, Coeffecient, Ithaka and individual investors have provided to Kate Farms since the early stages of our company's growth. Partners like Novo Holdings have enabled us to accelerate our business' trajectory, ultimately resulting in this exciting new chapter with Danone." As part of the transaction, Kate Farms will continue to operate as part of Danone's North America Medical Nutrition business. Effective immediately, Brett Matthews, who has served as Chairman and Chief Executive Officer of Kate Farms since 2015, will lead a team of great people with both heart and expertise in the combined business as Chairman and Chief Executive Officer of Danone's North America Medical Nutrition business. About Kate Farms Kate Farms was founded when a little girl named Kate was failing to thrive because she couldn't tolerate any of the available tube feeding formulas. Her determined parents, Richard and Michelle, had the transformative idea to develop a formula using high-quality, organic, and plant-based ingredients without the common allergens and ingredients often found in traditional formulas. Today, Kate is thriving, and Kate Farms is now the #1 Doctor Recommended Plant-Based Brand.* Kate Farms offers products for children and adults to be used as sole-source or supplemental nutrition for oral and tube feeding. They are available nationally and eligible for insurance coverage with Medicare, Medicaid, 31+ states for WIC† and private insurance. Kate Farms formulas are made with organic pea protein, fiber, and phytonutrients, and made without the top nine common allergens or artificial colors or flavors. Kate Farms can be accessed in more than 1,400 US hospitals. For more information on our full product portfolio, visit www.katefarms.com. *Independent plant-based formula survey. †WIC is a registered service mark of the U.S. Department of Agriculture for USDA's Special Supplemental Nutrition Program for Women, Infants, and Children. About Novo Holdings A/S Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people's health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S (Novozymes A/S) and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seed, Venture, Growth, Asia, Planetary Health and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development. As of year-end 2024, Novo Holdings had total assets of EUR 142 billion. www.novoholdings.dk About the Novo Nordisk Foundation Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people's health and the sustainability of society and the planet. The Foundation's mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.Cision View original content:https://www.prnewswire.com/news-releases/novo-holdings-portfolio-company-kate-farms-acquired-by-danone-302495959.html SOURCE Novo Holdings View Comments |
||
| 01.07.25 17:00:00 | Danone completes the acquisition of Kate Farms, enhancing its U.S. specialized nutrition offerings | |
| DANONE Press release – Paris, July 1st, 2025, at 7:00 P.M. CEST Danone completes the acquisition of Kate Farms, enhancing its U.S. specialized nutrition offerings Danone announced today that it has successfully completed the acquisition of a majority stake in Kate Farms, a fast-growing U.S. business and the #1 doctor-recommended plant-based brand in the U.S., offering a wide array of plant-based, organic nutrition products for both medical and everyday needs. By bringing together the Kate Farms, Nutricia, Real Food Blends, and Functional Formularies brands, the combined business will now reach more patients, consumers and healthcare providers in North America with a complementary and differentiated offering of high-quality nutritional solutions that support a wide range of health needs. In line with its Renew strategy, Danone’s newly enhanced medical nutrition business will boost availability and improve access to specialized nutrition – whether in hospitals, at home, online, or on shelf – meeting people wherever they are on their health journey. As previously announced, Danone will partner with Kate Farms’ senior management team to accelerate the growth trajectory of the combined business while continuing to deliver on Kate Farms’ mission to better serve patients, families and communities in the United States and abroad. Effective today, Brett Matthews, former CEO and Chairman of Kate Farms, will serve as the Chairman and Chief Executive Officer of the combined business. Brett Matthews, Danone North America Medical Nutrition Chairman and Chief Executive Officer said: "Becoming part of Danone – an organization that shares our mission to improve lives through nutrition – is a really proud moment for Kate Farms and will make a positive difference to the people, families and communities we serve. Together, we are in a better position to provide high-quality nutrition to those with a wide range of health needs. With Danone’s global expertise, broad U.S. footprint and deep commitment to science-based, patient-centered care, we will reach more people, expand our impact, and continue building an organization rooted in strong values, innovation and compassion. I’m honored to step into this new role leading the combined business and excited to work alongside our world-class teams at both Danone and Kate Farms to bring our hearts and expertise to support more people on their health journey. Together, we’ll ensure our brands flourish, support the important work healthcare professionals do every day and help people thrive.” Antoine de Saint-Affrique, Danone SA Chief Executive Officer said: "We are thrilled to welcome Brett Matthews and the Kate Farms team to the Danone family. This partnership is a significant step forward in our Specialized Nutrition journey and enhances our collective ability to serve patients and consumers with innovative solutions. Together, our combined organizations will accelerate growth, better serve communities and patients in the U.S. and continue to support healthier lives through nutrition that truly makes a difference." Story Continues o o O o o FORWARD-LOOKING STATEMENTS This press release contains certain forward-looking statements concerning Danone that are subject to risks and uncertainties. Generally, you can identify these forward-looking statements by forward-looking words, such as “estimate”, “expect”, “anticipate”, “project”, “plan”, “intend”, “objective”, “believe”, “forecast”, “guidance”, “foresee”, “likely”, “may”, “should”, “goal”, “target”, “might”, “will”, “could”, “predict”, “continue”, “convinced” and “confident,” the negative or plural of these words and other comparable terminology or by using future dates. Forward-looking statements in this press release include but are not limited to: statements regarding Danone’s operation of the Kate Farms business; the expected benefits of the transaction; and the future activities, operations, direction, performance and results of Danone. These forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking statements. For a detailed description of risks and uncertainties, please refer to the “Risk Factor” section of Danone’s Universal Registration Document (the current version of which is available at www.danone.com). Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell or a solicitation of an offer to buy Danone securities. About Danone (www.danone.com) Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal and environment impact. Danone has defined its Renew strategy to restore growth, competitiveness, and value creation for the long-term. With over 90,000 employees, and products sold in over 120 markets, Danone generated €27.4 billion in sales in 2024. Danone’s portfolio includes leading international brands (Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, among others) as well as strong local and regional brands (including AQUA, Blédina, Bonafont, Cow & Gate, Mizone, Oikos and Silk). Listed on Euronext Paris and present on the OTCQX platform via an ADR (American Depositary Receipt) program, Danone is a component stock of leading sustainability indexes including the ones managed by Moody’s and Sustainalytics, as well as MSCI ESG Indexes, FTSE4Good Index Series, Bloomberg Gender Equality Index, and Access to Nutrition Index. Danone’s ambition is to be B CorpTM certified at global level in 2025. About Kate Farms (www.katefarms.com) Kate Farms was founded when a little girl named Kate was failing to thrive because she couldn't tolerate any of the available tube feeding formulas. Her determined parents, Richard and Michelle, had the transformative idea to develop a formula using high-quality, organic, and plant-based ingredients without the common allergens and ingredients often found in traditional formulas. In 2015, Brett Matthews partnered with Richard and Michelle and became Chairman and CEO to build a great team of people and bring Kate Farms into healthcare to help people with health conditions. Kate Farms is the #1 doctor-recommended plant-based brand in the U.S.* Kate Farms provides nutritional formulas and shakes for children and adults, intended for both oral and tube feeding, whether as sole-source or supplemental nutrition. They are available nationally and eligible for insurance coverage with Medicare, Medicaid, private insurance, and in 33+ states via WIC†. All formulas and shakes are made with organic pea protein, fiber, and phytonutrients, and without the top nine allergens, artificial sweeteners, colors, or flavors. Today, Kate Farms can be found in more than 1,400 U.S. hospitals, online at www.katefarms.com, Amazon, and in select retail locations, with national expansion underway. For more information on our full product portfolio, visit www.katefarms.com. Former minority investors in Kate Farms include Novo Holdings, Goldman Sachs, Kaiser Ventures, Main Street Advisors, Coefficient, Aliment Capital, and Ithaka. †WIC is a registered service mark of the U.S. Department of Agriculture for USDA’s Special Supplemental Nutrition Program for Women, Infants, and Children. *Among surveyed doctors recommending plant-based nutrition products. Attachment prdanone010725 View Comments |
||
| 30.06.25 13:40:01 | Is Danone (DANOY) Stock Outpacing Its Consumer Staples Peers This Year? | |
| Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Is Danone (DANOY) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. Danone is one of 178 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #15 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Learn More Thor Metals Group: Best Overall Gold IRA Learn More Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Learn More Powered by Money.com - Yahoo may earn commission from the links above. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Danone is currently sporting a Zacks Rank of #2 (Buy). Over the past 90 days, the Zacks Consensus Estimate for DANOY's full-year earnings has moved 10.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving. Our latest available data shows that DANOY has returned about 21.5% since the start of the calendar year. Meanwhile, the Consumer Staples sector has returned an average of 4.9% on a year-to-date basis. This means that Danone is outperforming the sector as a whole this year. Another stock in the Consumer Staples sector, Heineken NV (HEINY), has outperformed the sector so far this year. The stock's year-to-date return is 21.9%. In Heineken NV's case, the consensus EPS estimate for the current year increased 3.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy). To break things down more, Danone belongs to the Food - Miscellaneous industry, a group that includes 41 individual companies and currently sits at #182 in the Zacks Industry Rank. On average, stocks in this group have lost 4.7% this year, meaning that DANOY is performing better in terms of year-to-date returns. Heineken NV, however, belongs to the Beverages - Alcohol industry. Currently, this 17-stock industry is ranked #52. The industry has moved +0.5% so far this year. Going forward, investors interested in Consumer Staples stocks should continue to pay close attention to Danone and Heineken NV as they could maintain their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Danone (DANOY) : Free Stock Analysis Report Heineken NV (HEINY) : Free Stock Analysis Report Story Continues This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments |
||
| 25.06.25 17:15:00 | The Akkermansia Company is Acquired by Danone | |
| The Akkermansia Company Danone Invests Further in Gut Health and Next-Generation Biotic Science WILMINGTON, Del., June 25, 2025 (GLOBE NEWSWIRE) -- The Akkermansia Company (TAC) today announces that it has been acquired by Danone, a leading global food and beverage company. TAC’s founding scientists first discovered the biotic strain Akkermansia muciniphila MucT in 2004 and have since developed it using state-of-the-art technology. They clinically demonstrated its power to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes and cardiovascular disease. The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT, which is its most bio-efficacious form. TAC is successfully expanding business into key markets in Europe, North America and Asia. “We are very excited about becoming part of the Danone family. It provides us with the resources to accelerate global growth of the pasteurized Akkermansia muciniphila MucT strain and develop our brands faster,” said Michael Oredsson, CEO of TAC. “I am confident that with Danone we will move faster to our goal of giving billions of consumers the opportunity to benefit from improved metabolic health offered by Akkermansia,” said TAC’s Chief Technology Officer, Professor Willem M. DeVos, who discovered Akkermansia and co-founded the company. About The Akkermansia Company An international leader in developing next-generation probiotic and postbiotic supplements, The Akkermansia Company is on a mission to shift the focus of the microbiome health paradigm from symptoms to root cause. Founded by Professor Willem M. de Vos and Professor Patrice D. Cani, the company developed Akkermansia muciniphila MucT®, which plays a major role in helping to maintain a healthy gut microbiome and in maintaining metabolic health. After becoming available in its Belgian home market in 2021, the company is now expanding sales of Akkermansia muciniphila MucT® into key markets in Europe, North America and Asia. Learn more at theakkermansiacompany.com and follow The Akkermansia Company on Facebook and Instagram. MEDIA CONTACT: Lisa Lazarczyk, LAZ PR Tel: 617.838.7327 or lisa@lazpr.com View Comments |
||
| 25.06.25 16:00:00 | Danone further invests in gut health and next-generation biotic research with the acquisition of The Akkermansia Company | |
| DANONE Press release – Paris, June 25, 2025, at 18:00 CEST Danone further invests in gut health and next-generation biotic research with the acquisition of The Akkermansia Company Danone today announces the acquisition of The Akkermansia Company (TAC), a Belgian company with nearly 20 years of history and science, specializing in biotics. In 2004, using state-of-the-art technology, scientists at TAC discovered and developed a biotic strain, Akkermansia muciniphila MucT™. They clinically demonstrated its power to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes, and cardiovascular disease. Expanding deeper into gut health is a key facet of Danone’s Renew strategy, as it doubles down on science and innovation, and as consumer interest in healthy products continues to rise. About Danone (www.danone.com) Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal and environment impact. Danone has defined its Renew strategy to restore growth, competitiveness, and value creation for the long-term. With over 90,000 employees, and products sold in over 120 markets, Danone generated €27.4 billion in sales in 2024. Danone’s portfolio includes leading international brands (Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, among others) as well as strong local and regional brands (including AQUA, Blédina, Bonafont, Cow & Gate, Mizone, Oikos and Silk). Listed on Euronext Paris and present on the OTCQX platform via an ADR (American Depositary Receipt) program, Danone is a component stock of leading sustainability indexes including the ones managed by Moody’s and Sustainalytics, as well as MSCI ESG Indexes, FTSE4Good Index Series, Bloomberg Gender Equality Index, and Access to Nutrition Index. Danone’s ambition is to be B CorpTM certified at global level in 2025. o o O o o FORWARD-LOOKING STATEMENTS This press release contains certain forward-looking statements concerning Danone that are subject to risks and uncertainties. Generally, you can identify these forward-looking statements by forward-looking words, such as “estimate”, “expect”, “anticipate”, “project”, “plan”, “intend”, “objective”, “believe”, “forecast”, “guidance”, “foresee”, “likely”, “may”, “should”, “goal”, “target”, “might”, “will”, “could”, “predict”, “continue”, “convinced” and “confident,” the negative or plural of these words and other comparable terminology or by using future dates. Forward-looking statements in this press release include but are not limited to predictions of future activities, operations, direction, performance and results of Danone. These forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking statements. For a detailed description of risks and uncertainties, please refer to the “Risk Factor” section of Danone’s Universal Registration Document (the current version of which is available at www.danone.com). Story Continues Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell or a solicitation of an offer to buy Danone securities. Attachment prdanone250625 View Comments |
||
| 16.06.25 15:53:00 | Danone: Information on the total number of voting rights and shares | |
| DANONE DANONE French Société anonyme with a capital of €170,267,100,00. Registered Office: 17, boulevard Haussmann, 75009 Paris. Registered with the Paris Commerce and Company Registry under number 552 032 534 Information on the total number of voting rights and shares in compliance with Article L. 233-8 II of the French Commercial Code and with Article 223-16 of the General Regulation of the Financial Markets Authority (AMF- Autorité des Marchés Financiers) Date Total number of shares Total number of voting rights 31/05/2025 681,068,400 Total number of theoretical voting rights(1) : 718,099,987 Total number of exercisable voting rights(2) : 680,003,319 (1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. (2) The total number of exercisable voting rights (or ”net” voting rights) is calculated without taking into account the shares with suspended voting rights. It is published to ensure that the public is properly informed in accordance with the recommendation made by the AMF on July 17, 2007. Attachment Voting Rights and Shares 310525 View Comments |
||
| 13.06.25 15:40:02 | INGR or DANOY: Which Is the Better Value Stock Right Now? |  |
| Investors looking for stocks in the Food - Miscellaneous sector might want to consider either Ingredion (INGR) or Danone (DANOY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits. Advertisement: High Yield Savings Offers Earn 4.10% APY** on balances of $5,000 or more View Offer Earn up to 4.00% APY with Savings Pods View Offer Earn up to 3.80% APY¹ & up to $300 Cash Bonus with Direct Deposit View Offer Powered by Money.com - Yahoo may earn commission from the links above. Right now, both Ingredion and Danone are sporting a Zacks Rank of #2 (Buy). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that these stocks have improving earnings outlooks. But this is just one piece of the puzzle for value investors. Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels. Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use. INGR currently has a forward P/E ratio of 12.34, while DANOY has a forward P/E of 20.04. We also note that INGR has a PEG ratio of 1.12. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. DANOY currently has a PEG ratio of 6.49. Another notable valuation metric for INGR is its P/B ratio of 2.24. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, DANOY has a P/B of 2.98. Based on these metrics and many more, INGR holds a Value grade of A, while DANOY has a Value grade of C. Both INGR and DANOY are impressive stocks with solid earnings outlooks, but based on these valuation figures, we feel that INGR is the superior value option right now. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ingredion Incorporated (INGR) : Free Stock Analysis Report American Express Company (AXP) : Free Stock Analysis Report Danone (DANOY) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments |
||
| 12.06.25 13:40:09 | Is Danone (DANOY) Outperforming Other Consumer Staples Stocks This Year? | |
| Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Is Danone (DANOY) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Consumer Staples peers, we might be able to answer that question. Advertisement: High Yield Savings Offers Earn 4.10% APY** on balances of $5,000 or more View Offer Earn up to 4.00% APY with Savings Pods View Offer Earn up to 3.80% APY¹ & up to $300 Cash Bonus with Direct Deposit View Offer Powered by Money.com - Yahoo may earn commission from the links above. Danone is a member of our Consumer Staples group, which includes 178 different companies and currently sits at #13 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Danone is currently sporting a Zacks Rank of #2 (Buy). The Zacks Consensus Estimate for DANOY's full-year earnings has moved 8.1% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend. Based on the latest available data, DANOY has gained about 25.2% so far this year. Meanwhile, stocks in the Consumer Staples group have gained about 6.6% on average. This shows that Danone is outperforming its peers so far this year. Another Consumer Staples stock, which has outperformed the sector so far this year, is Heineken NV (HEINY). The stock has returned 30% year-to-date. For Heineken NV, the consensus EPS estimate for the current year has increased 1.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Breaking things down more, Danone is a member of the Food - Miscellaneous industry, which includes 41 individual companies and currently sits at #149 in the Zacks Industry Rank. Stocks in this group have lost about 4.1% so far this year, so DANOY is performing better this group in terms of year-to-date returns. Heineken NV, however, belongs to the Beverages - Alcohol industry. Currently, this 17-stock industry is ranked #93. The industry has moved +5.3% so far this year. Investors interested in the Consumer Staples sector may want to keep a close eye on Danone and Heineken NV as they attempt to continue their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Danone (DANOY) : Free Stock Analysis Report Heineken NV (HEINY) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments |
||
